Measurement of body surface energy leakage of defibrillation shock by an implantable cardioverter defibrillator

PACE-Pacing and Clinical Electrophysiology

Volumn 25, Issue 8, 2002, Pages 1212-1218

  Niwano, Shinichi ^a   Kojima, Jisho ^a   Inuo, Kimiatsu ^a   Saito, Junko ^a   Kashiwa, Tetsuo ^b   Suyama, Makoto ^b   Toyoshima, Takeshi ^b   Aizawa, Yoshifusa ^c,d   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tachy Business Group   (Japan)

^c Medtronic Japan Co Ltd   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

Antitachycardia device; Defibrillation; Electrical shock; Electrical stimulation; Tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DISEASE SEVERITY; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTRIC SHOCK; ELECTROSTIMULATION; ENERGY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPEDANCE; MALE; SKIN ELECTRODE;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC IMPEDANCE; ELECTRICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR;

EID: 0036692915     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01212.x     Document Type: Article

References (30)

1. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
2. Long-term outcome with the automatic implantable cardioverter-defibrillator
3. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
4. The antitachycardia pacing ICD: Impact on patient selection and outcome
5. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)
6. Clinical outcome of patients with malignant ventricular tachyarrhythmias and multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study
7. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead system
8. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
9. Influence of patient characteristics in the selection of patients for defibrillator implantation (the AVID Registry). Antiarrhythmics Versus Implantable Defibrillators
10. The AVID trial: Evidence based or randomized control trials-Is the AVID study too late? Antiarrhythmics Versus Implantable Defibrillators
11. Clinical and socioeconomic profile of patients with malignant ventricular arrhythmias in 1993 to 1995
12. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients
13. Experimental ventricular defibrillation with an automatic and completely implanted system
14. Electric shock harzard to second party from automatic implanted defibrillator
15. Electrical shock in pregnancy: A case report
16. Electrical accidents during pregnancy
17. American Heart Association: Guidelines for cardiopulmonary resuscitation and emergency cardiac care
18. Thermal injury kinetics in electrical trauma
19. Electrical shock and lightning strike
20. Electrical shock injury
21. Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches
22. Measurement of body-surface leakage energy of defibrillation shock by an implantable cardioverter-defibrillator (ICD) system. Experimental evaluation during defibrillation shocks through the right ventricular lead and the subcutaneous active-can in canines
23. Initial experience of implantable cardioverter-defibrillator treatment in patients with ventricular tachyarrhythmias
24. The usefulness of Holter monitoring in selecting pharmacological therapy for patients with sustained monomorphic ventricular tachycardia. Studies in patients in whom no effective pharmacological therapy could be determined by electrophysiologic study
25. Complications associated with pectoral implantation of cardioverter defibrillators
26. A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system
27. The effect of polarity of the initial phase of a biphasic shock waveform on the defibrillation threshold of pectorally implanted defibrillators
28. Report of the NASPE Policy Conference training requirements for permanent pacemaker selection, implantation, and follow-up
29. The safety and efficacy of chronic ventricular pacing at 1.6 volts using a steroid eluting lead
30. The electrode-tissue interface: The revolutionary role of steroid elution